News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Judith D. Bebchuk

Articles by Judith D. Bebchuk

TPS 105 ALISertib in Combination With Endocrine Therapy in Patients With Hormone Receptor-Positive, HER2-Negative Recurrent or Metastatic Breast Cancer: the Phase 2 ALISCA-Breast1 Study

ByPooja Advani, MBBS, MD,Sofia Braga,Adam M. Brufsky, MD, PhD,Karthik V. Giridhar,Erica L. Mayer, MD, MPH,Kelly E. McCann,Ruth M. O’Regan,Cristina Saura,Seth A. Wander,Georg F. Bischof,Beth H. Lowenthal,Judith D. Bebchuk,Lisa D. Eli,Brian G. Barnett,Joyce A. O’Shaughnessy,Tufia C. Haddad

April 11th 2025

Latest Updated Articles

Trending on CancerNetwork

MATTERHORN Results Yield Promise in Resectable Gastric/GEJ Cancer

Pelareorep Exhibits Activity in Second-Line KRAS-Mutated Metastatic CRC

RAD 101 Imaging Agent Achieves Concordance with MRI in Suspected Brain Mets

FDA Approves T-DXd Plus Pertuzumab in Metastatic HER2+ Breast Cancer

SLNB Omission in Early Breast Cancer: Clinical Implications of SOUND and INSEMA

© 2025 MJH Life Sciences^®

All rights reserved.